Brief: Japan's Astellas To Close Biopharmaceutical Manufacturing Facility In California This Fiscal Year, Nikkei Says
08/10/2024 10:03
Oct 8 (Reuters) - Astellas Pharma Inc 4503.T :
* JAPAN'S ASTELLAS TO CLOSE BIOPHARMACEUTICAL MANUFACTURING FACILITY IN
CALIFORNIA THIS FISCAL YEAR, NIKKEI SAYS
* ASTELLAS PLANT CLOSURE TO AFFECT ABOUT 100 WORKERS, NIKKEI SAYS
Source text for Eikon: ID:
Further company coverage: 4503.T
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn